Why It Works: GLP-1 and GIP reduce hunger and improve insulin sensitivity Glucagon receptor activation increases energy expenditure and fat oxidation 2
Br J Pharmacol 2016, 173(11): 1820-1834
Retatrutide adds glucagon receptor activation, creating a triple agonist with additional metabolic benefits including increased energy expenditure and enhanced fat metabolism
Szsz, et al., 'Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer's Disease', Pharmaceuticals , vol
As research continues, healthcare providers are optimistic that tirzepatide may become a cornerstone in the treatment of type 2 diabetes, potentially changing the landscape of diabetes management for many patients
Many users find that transitioning to maintenance doses rather than complete discontinuation better preserves improvements